|
National Stock Number(NSN): 6505-01-491-6143 (6505014916143, 014916143)
| NIIN: |
01-491-6143 |
Item Name: |
CIPROFLOXACIN TABLETS |
INC: |
45499
|
| FSC: |
6505
|
Assignment Date: |
Oct-26-2001 |
CRIT: |
X |
IIG: |
45499 |
| ISC: |
2 |
Date Standardized: |
Oct-26-2001 |
HMIC: |
P |
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Jun-01-2020 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9210 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-333-4154 |
Item Name: |
CIPROFLOXACIN TABLETS |
| FSC: |
6505 |
Replacement Date: |
Jun-01-2020 |
|
INC: |
45499 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
01-0644 |
89875
|
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
103481 |
0PTU3
|
PD-RX PHARMACEUTICALS, INC. |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
6505NCM010484 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
CIPRO-10S |
13521
|
BAYER CORPORATION |
H |
5 |
9 |
4 |
ZZ |
|
B |
|
|
|
|
|
NDC55289-0821-10 |
0PTU3
|
PD-RX PHARMACEUTICALS, INC. |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
SMS |
Y |
|
Q |
U |
0 |
A |
$0.01 |
PG |
|
C2201X- |
May-01-2020 |
H |
| DF |
|
Y |
|
|
|
|
F |
$0.00 |
PG |
|
------- |
Apr-01-2003 |
H |
| DM |
SMS |
Y |
Z |
Q |
U |
0 |
M |
$0.01 |
PG |
|
15B2--- |
May-01-2020 |
H |
| DN |
SMS |
Y |
|
Q |
U |
0 |
N |
$0.01 |
PG |
|
9B----- |
May-01-2020 |
H |
| DS |
SMS |
Y |
N |
Q |
U |
0 |
D |
$0.01 |
PG |
|
------- |
May-01-2020 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DF |
N |
DISPOSAL |
000 |
|
|
|
| DM |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| CBBL |
FEATURES PROVIDED |
INDIVIDUALLY SEALED |
| CQCT |
PRIMARY CONTAINER TYPE |
STRIP |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
10.000 TABLETS |
| CSGS |
ADMINISTRATION |
ORAL |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
CIPROFLOXACIN TABLETS USP 500MG I.S. 10S PG |
| FEAT |
SPECIAL FEATURES |
500 MG CIPROFLOXACIN HYDROCHLORIDE ACTIVE INGREDIENT,ARMY OWNED PRODUCT;THIS NSN REPRESENTS A PACKAGE SIZE PREPARED BY REPLACING BULK MATERIAL; THE NSN WAS CREATED TO PERMIT INVENTORY MANAGEMENT OF THE REPACKAGED DOSAGE FORM; THE NSN IS NOT PROCURABLE; DO NOT REQUISITION CIPROFLOXACIN TABLETS, USP, 500 MG I.S. 10'S PACKAGE; THE LABEL FOR THIS NSN CONTAINS DIRECTIONS TO TAKE ONE DOSE EVERY 12 HOURS TO REDUCE THE CHANCE OF INFECTION AFTER EXPOSURE TO BIOLOGICAL AGENTS |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A911 |
A111 |
Dec-01-2006 |
3 |
Z |
|
|
AM|GX |
AM|BN|GX |
| MC55 |
|
Jan-20-2012 |
3 |
Z |
|
|
GX|PA |
GX|PA |
| N9BL |
|
Mar-17-2011 |
3 |
Z |
|
|
GX |
GH|GX|GG |
| Description: |
DRUGS/MEDICINES/VITAMINS NOI |
Originating Activity: |
KX |
| Hazardous Material: |
|
National Motor Freight Classification Number: |
058770 |
| Less Than One Truckload: |
W |
NMFC Sub-Item: |
Z |
| Uniform Freight Classification Number: |
33400 |
Rail Variance Code: |
|
| Less Than One Carload: |
|
Water Commodity Code: |
532 |
| Type of Cargo Code: |
Z |
Special Handling Code: |
9 |
| Air Commodity Special Handling Code: |
MZ |
Air Dimension Code: |
A |
|